LBA10 Sotorasib versus docetaxel for previously treated non-small cell lung cancer with KRAS G12C mutation: CodeBreaK 200 phase III study

M.L. Johnson, A.J. de Langen, D.M. Waterhouse, J. Mazieres, Anne‐Marie C. Dingemans, G. Mountzios, M. Pless, J. Wolf, M. Schuler, H. Lena, F. Skoulidis, I. Okamoto, S-W. Kim, H. Linardou, Silvia Novello, Yueyun Chen, B. Solomon, C. Obiozor, Y. Wang, L. Paz-Ares